Literature DB >> 7109028

Infectious cell entry mechanism of influenza virus.

A Yoshimura, K Kuroda, K Kawasaki, S Yamashina, T Maeda, S Ohnishi.   

Abstract

Interaction between influenza virus WSN strain and MDCK cells was studied by using spin-labeled phospholipids and electron microscopy. Envelope fusion was negligibly small at neutral pH but greatly activated in acidic media in a narrow pH range around 5.0. The half-time was less than 1 min at 37 degrees C at pH 5.0. Virus binding was almost independent of the pH. Endocytosis occurred with a half-time of about 7 min at 37 degrees C at neutral pH, and about 50% of the initially bound virus was internalized after 1 h. Electron micrographs showed binding of virus particles in coated pits in the microvillous surface of plasma membrane and endocytosis into coated vesicles. Chloroquine inhibited virus replication. The inhibition occurred when the drug was added not later than 10 min after inoculation. Chloroquine caused an increase in the lysosomal pH 4.9 to 6.1. The drug did not affect virus binding, endocytosis, or envelope fusion at pH 5.0. Electron micrographs showed many virus particles remaining trapped inside vacuoles even after 30 min at 37 degrees C in the presence of drug, in contrast to only a few particles after 10 min in vacuoles and secondary lysosomes in its absence. Virus replication in an artificial condition, i.e., brief exposure of the inoculum to acidic medium followed by incubation in neutral pH in the presence of chloroquine, was also observed. These results are discussed to provide a strong support for the infection mechanism of influenza virus proposed previously: virus uptake by endocytosis, fusion of the endocytosed vesicles with lysosome, and fusion of the virus envelope with the surrounding vesicle membrane in the secondary lysosome because of the low pH. This allows the viral genome to enter the target cell cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7109028      PMCID: PMC256119          DOI: 10.1128/JVI.43.1.284-293.1982

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

Authors:  S G Lazarowitz; P W Choppin
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus).

Authors:  Y Okada; I Koseki; J Kim; Y Maeda; T Hashimoto
Journal:  Exp Cell Res       Date:  1975-07       Impact factor: 3.905

3.  A spin-label study on fusion of red blood cells induced by hemagglutinating virus of Japan.

Authors:  T Maeda; A Asano; K Oki; Y Okada; S Onishi
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

4.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

5.  Electron microscopic observations on the entry of influenza virus into susceptible cells.

Authors:  R R Dourmashkin; D A Tyrrell
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

6.  Inside-outside transitions of phospholipids in vesicle membranes.

Authors:  R D Kornberg; H M McConnell
Journal:  Biochemistry       Date:  1971-03-30       Impact factor: 3.162

7.  Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride.

Authors:  N Kato; H J Eggers
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

8.  Structure and development of viruses as observed in the electron microscope. 8. Entry of influenza virus.

Authors:  C Morgan; H M Rose
Journal:  J Virol       Date:  1968-09       Impact factor: 5.103

9.  Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties.

Authors:  M B Goren
Journal:  Biochim Biophys Acta       Date:  1970-06-09

10.  Replication and plaque assay of influenza virus in an established line of canine kidney cells.

Authors:  C R Gaush; T F Smith
Journal:  Appl Microbiol       Date:  1968-04
View more
  59 in total

1.  Initial events in infectious salmon anemia virus infection: evidence for the requirement of a low-pH step.

Authors:  T M Eliassen; M K Frøystad; B H Dannevig; M Jankowska; A Brech; K Falk; K Romøren; T Gjøen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion.

Authors:  Brent J Ryckman; Michael A Jarvis; Derek D Drummond; Jay A Nelson; David C Johnson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.

Authors:  M J Clague; C Schoch; R Blumenthal
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?

Authors:  S Yoden; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.

Authors:  T Bächi; W Gerhard; J W Yewdell
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

7.  Oligomeric structure of a prototype retrovirus glycoprotein.

Authors:  D Einfeld; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

Authors:  S M de Boer; J Kortekaas; L Spel; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Stability of infectious influenza A viruses to treatment at low pH and heating.

Authors:  C Scholtissek
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.